Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 26, Merck & Co., Inc.

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

Merck is closing in on a $10bn (€8.5bn) deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported.

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

The FDA has started a review of MSD's RSV antibody clesrovimab, a potential rival to Beyfortus, with a verdict due in the middle of next year.

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...

The Centers for Disease Control and Prevention (CDC) yesterday declared its investigation into a multistate Salmonella ...

The awards will be handed out at a gala event scheduled for October 9 at New York City’s Cipriani Wall Street.

If I have sounded like a broken record these past months, it is because these developments in American public health are as ...

Merck’s RSV shot for infants cleared in U.S., challenging Sanofi/Astra’s dominance SA NewsTue, Jun. 10 5 Comments 2 3 4 5 ...